Systemic exposure to intracameral vs topical mydriatic agents: in cataract surgery
Jose Guell,1 Anders Behndig,2 Uwe Pleyer,3 Stéphane Jaulerry,4 Pascal Rozot,5 Pierre-Jean Pisella,6 Pierre-Yves Robert,7 Ines Lanzl,8 Sayeh Pourjavan,9 Carlos Aguiar,10 Joaquin Fernandez,11 Gunther Grabner,12 Rita Mencucci,13 Frédéric Chiambaretta,14 Marc Labetoulle1...
Guardado en:
Autores principales: | Guell J, Behndig A, Pleyer U, Jaulerry S, Rozot P, Pisella PJ, Robert PY, Lanzl I, Pourjavan S, Aguiar C, Fernandez J, Grabner G, Mencucci R, Chiambaretta F, Labetoulle M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0ad0ca44d77b4bd39647b4d62d923e1a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparison of the frequency of use of a pupil expansion device with and without an intracameral phenylephrine and ketorolac injection 1%/0.3% at the time of routine cataract surgery
por: Bucci Jr FA, et al.
Publicado: (2017) -
Efficacy of Nepafenac versus Flurbiprofen in Maintaining Intraoperative Mydriasis During Phacoemulsification: A Comparative Study
por: Shrivastava AK, et al.
Publicado: (2021) -
Intracameral ketorolac concentration at the beginning and end of cataract surgery following preoperative topical ketorolac administration
por: Katsev DA, et al.
Publicado: (2017) -
Intracameral dexamethasone injection in the treatment of cataract surgery induced inflammation: design, development, and place in therapy
por: Shah TJ, et al.
Publicado: (2018) -
Clinical Evaluation of a Novel Electromechanical Topical Ocular Drug Delivery System: Two Phase 1 Proof of Concept Studies
por: Quiroz-Mercado H, et al.
Publicado: (2020)